Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-03-13FDA Approved: TYENNE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for TYENNE (tocilizumab-AAZG) from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis [Phase 2]
Phase 2 clinical trial evaluating the impact of cannabis on pain and inflammation in rheumatoid arthritis and psoriatic arthritis. The study…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
A Strasbourg-based study is evaluating whether physician consideration of electronic patient-reported outcomes from patients with gout, rheu…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA) [Phase 3]
A Phase 3 clinical trial is evaluating spironolactone for efficacy in rheumatoid arthritis and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide [Phase 4]
A Phase 4 clinical trial from University Hospital, Strasbourg, France, is recruiting rheumatoid arthritis patients with inadequate response …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Long-term Outcomes of Patients with Rheumatoid Arthritis in Remission
ClinicalTrials.gov entry describing a study on long-term outcomes of patients with rheumatoid arthritis who are in remission; the trial is c…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan [Phase 4]
A Phase 4 trial from Keio University evaluates the optimal methotrexate dose as add-on therapy to adalimumab in rheumatoid arthritis patient…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects With Rheumatoid Arthritis Partially Responsive to Methotrexate Therapy [Phase 2]
A Phase 2 study by Amgen evaluated the safety and efficacy of CCX354-C in rheumatoid arthritis patients partially responsive to methotrexate…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis
A completed clinical trial assesses whether a test reflecting immunological remission can predict discontinuation of abatacept in rheumatoid…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease
A completed study evaluating the construct validity and responsiveness of the EQ-5D-3L health-status instrument in patients with rheumatic d…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Study to Evaluate Safety and Efficacy of CCX 354-C in Subjects With Rheumatoid Arthritis [Phase 1, Phase 2]
Amgen completed a combined Phase 1/2 trial to evaluate the safety and efficacy of CCX-354-C in rheumatoid arthritis.
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: The Oxylipin Response as a New PrEdictive Biomarker of Patient Responsiveness to Biotherapy in Rheumatoid Arthritis (OPERA) [NA]
This clinical trial update discusses the OPERA study evaluating whether oxylipin response can predict which rheumatoid arthritis patients wi…
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: The Relationship of Hand Sensory and Strength Assessments with Functionality and Kinesiophobia in Individuals with Rheumatoid Arthritis
This clinical trial from Firat University examines how hand sensory and strength assessments relate to functionality and kinesiophobia in in…
-
EMA approval · 2025-03-03EMA Authorised: Nepexto (etanercept) — Biosimilar Collaborations Ireland Limited
EMA authorised Nepexto, a biosimilar of etanercept, developed by Biosimilar Collaborations Ireland Limited, for several inflammatory arthrit…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Safety and Efficacy of SWK002 in Patients With D2T-Rheumatoid Arthritis [NA]
Ongoing clinical trial assessing the safety and efficacy of SWK002 in patients with rheumatoid arthritis; recruitment is currently ongoing.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis [Phase 3]
This clinical trial update notes that the Phase 3 extension study of TS-152 in rheumatoid arthritis has been completed.
-
FDA approval · 2025-02-27FDA Approved: DICLOFENAC SODIUM/MISOPROSTOL DICLOFENAC-SODIUM-MISOPROSTOL — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for Diclofenac Sodium/Misoprostol (Diclofenac-Sodium-Misoprostol) from Micro Labs Limited.
-
CLINICAL_TRIALS withdrawal · 2025-02-27Clinical Trial Update: ELECTOR Treat-to-target Via Home-based Disease Activity Monitoring of Patients With Rheumatoid Arthritis [NA]
The ELECTOR trial evaluating treat-to-target using home-based disease activity monitoring for rheumatoid arthritis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only
This update notes ongoing post-market clinical follow-up for Exactech's Vantage Total Ankle System in the United States, with recruitment cu…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Vantage Mobile Bearing Total Ankle System Post Market Clinical Follow-up (Outside US)
A post-market clinical follow-up trial outside the United States evaluating the Vantage Mobile Bearing Total Ankle System, sponsored by Exac…
-
FDA approval · 2025-02-26FDA Approved: CELECOXIB — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for Celecoxib (celecoxib), authorizing a generic version under the ANDA pathway. The ac…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis [Phase 4]
This Phase 4 trial investigated the effects of methotrexate on blood pressure and arterial function in rheumatoid arthritis and has complete…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: EFFECTS OF ABATACEPT on the Progression to Rheumatoid Arthritis(PALABA Study) [Phase 4]
Phase 4 PALABA study evaluating whether abatacept can influence progression from palindromic rheumatism to rheumatoid arthritis; study statu…
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: An Alternative Assessment in Patients with Rheumatoid Arthritis: 6 Minute Step Test [NA]
A clinical trial update describes using a 6-minute step test as an alternative assessment in patients with rheumatoid arthritis, and the stu…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: SMR Stemless Shoulder Arthroplasty Clinical Study [NA]
A completed clinical study of the SMR Stemless Shoulder Arthroplasty sponsored by Limacorporate S.p.a. evaluating outcomes in shoulder osteo…